natgillin/translations-raw huggingface dataset:
Significant improvement (p<0.01) in the 6MWD was demonstrated at week 12 when the patients were asked to delay taking study medicinal product in order to reflect trough active substance concentration.
Signifikantno izboljšanje (p<0,01) pri 6MWD je bilo vidno v 12. tednu, ko je bilo bolnikom naročeno, naj počakajo z jemanjem naslednjega odmerka preučevanega zdravila, da bi se ugotovile najnižje koncentracije učinkovine.
Of these, 311 patients had been treated with tadalafil for at least 6 months and 293 for 1 year (median exposure 365 days; range 2 days to 415 days).
Od teh se je 311 bolnikov s tadalfilom zdravilo najmanj 6 mesecev, 293 pa 1 leto (mediana izpostavljenost je bila 365 dni, razpon od 2 dni do 415 dni).
The improvement in walk distance was apparent from 8 weeks of treatment.
Izboljšanje 6MWD je bilo opazno po 8 tednih zdravljenja.
Adverse reaction data are limited in patients over 75 years of age.
Podatki o neželenih učinkih pri bolnikih nad 75 let so omejeni.
The tablets can be taken with or without food.
Zdravilo ADCIRCA lahko vzamete s hrano ali brez nje.
What ADCIRCA is and what it is used for What you need to know before you take ADCIRCA How to take ADCIRCA
Kaj je zdravilo ADCIRCA in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo ADCIRCA Kako jemati zdravilo ADCIRCA
The mean age of all patients was 54 years (range 14 to 90 years) with the majority of patients being Caucasian (80.5 %) and female (78.3 %).
Srednja starost bolnikov je bila 54 let (od 14 do 90 let), večina je bila kavkaške rase (80,5 %) in ženskega spola (78,3 %).
Do not breastfeed while taking these tablets as it is not known if the medicine passes into human breast milk.
Med jemanjem tablet ne dojite, saj ni znano, ali zdravilo prehaja v mleko.
The majority of patients had a World Health Organization (WHO) Functional Class III (65.2 %) or II (32.1 %).
Večina bolnikov je bila v funkcijskem razredu III (65,2 %) ali II (32,1 %) po razvrstitvi Svetovne zdravstvene organizacije (SZO).
- priapism, a prolonged and possibly painful erection after taking ADCIRCA (frequency uncommon).
• priapizem, podaljšana in morda boleča erekcija po jemanju zdravila ADCIRCA (pojavi se redko).
Although other risk factors were present in some cases (such as age, diabetes, hypertension, previous hearing loss history and associated connective tissue diseases) patients should be advised to seek prompt medical attention in the event of sudden decrease or loss of hearing.
Čeprav so bili v določenih primerih prisotni drugi dejavniki tveganja (npr. starost, sladkorna bolezen, hipertenzija, predhodna izguba sluha v anamnezi in povezane bolezni veznega tkiva), je treba bolnikom svetovati, naj v primeru nenadnega poslabšanja ali izgube sluha poiščejo takojšnjo zdravniško pomoč.
In interaction studies performed in a limited number of healthy volunteers, these effects were not reported with alfuzosin or tamsulosin.
V študijah interakcij, ki so jih na majhnem številu zdravih prostovoljcev opravili z alfuzocinom ali tamsulozinom, o teh učinkih niso poročali.
Aluminium/PVC/PE/PCTFE blisters in cartons of 28 and 56 film-coated tablets.
Pretisni omoti aluminij/PVC/PE/ PCTFE v škatlah s po 28 ali 56 filmsko obloženimi tabletami.
Do not use this medicine after the expiry date stated on the carton and blister after ‘EXP'.
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in pretisnem omotu poleg oznake 'EXP'.
The results suggest a lower clearance of tadalafil in patients with pulmonary hypertension compared to healthy volunteers.
Rezultati kažejo na nižji očistek tadalafila pri bolnikih s pljučno hipertenzijo v primerjavi z zdravimi prostovoljci.
ADCIRCA has been shown to increase the effects of these medicines.
Za zdravilo ADCIRCA je bilo namreč ugotovljeno, da učinke teh zdravil poveča.
Some medicines may be affected by ADCIRCA or they may affect how well ADCIRCA will work.
Zdravilo ADCIRCA lahko vpliva na nekatera zdravila ali pa lahko zdravila vplivajo na delovanje zdravila ADCIRCA.
As this may be relevant for all patients exposed to tadalafil, the patient should be advised that in case of sudden visual defect, he should stop taking ADCIRCA and consult a physician immediately (see section 4.3).
Ker je to morda pomembno za vse bolnike, ki so izpostavljeni tadalafilu, je treba bolnika opozoriti, da naj v primeru nenadne okvare vida preneha jemati zdravilo ADCIRCA in o tem nemudoma obvesti svojega zdravnika (glejte poglavje 4.3).
ADCIRCA with alcohol
Zdravilo ADCIRCA skupaj z alkoholom
ADCIRCA has negligible influence on the ability to drive or use machines.
Zdravilo ADCIRCA ima zanemarljiv vpliv na sposobnost vožnje ali upravljanja s stroji.
MARKETING AUTHORISATION NUMBER(S) EU/1/08/476/005-006
ŠTEVILKA (ŠTEVILKE) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/08/476/005-006
The time of dosing (morning versus evening after a single 10 mg administration) had no clinically relevant effects on the rate and extent of absorption.
Čas odmerjanja (zaužitje enkratnega odmerka 10 mg zjutraj v primerjavi z zvečer) ni imel klinično pomembnih učinkov na stopnjo in obseg absorpcije.
PDE5 inhibitors are also used for the treatment of erectile dysfunction in men.
Zaviralci PDE5 se uporabljajo tudi za zdravljenje erektilne disfunkcije pri moških.
Do not take ADCIRCA when pregnant, unless it is strictly necessary and you have discussed this with your doctor.
Če ste noseči, zdravila ADCIRCA ne uporabljajte, razen če je to nujno potrebno in ste se o tem pogovorili s svojim zdravnikom.
Tadalafil is excreted predominantly as inactive metabolites, mainly in the faeces (approximately 61 % of the dose) and to a lesser extent in the urine (approximately 36 % of the dose).
Tadalafil se izloča predvsem v obliki neaktivnih presnovkov, večinoma z blatom (približno 61 % odmerka), v manjšem obsegu pa z urinom (približno 36 % odmerka).
Treatments for erectile dysfunction
Zdravljenje erektilne disfunkcije
The mean volume of distribution is approximately 77 l at steady state, indicating that tadalafil is distributed into tissues.
Povprečni volumen porazdelitve v stanju dinamičnega ravnovesja je približno 77 l, kar kaže, da se tadalafil razporeja po tkivih.
Three hundred and fifty seven (357) patients who completed the pivotal study entered a long-term extension study.
Tristo sedeminpetdeset (357) bolnikov, ki so dokončali to ključno študijo, je bilo vključenih v dolgoročno podaljšano študijo.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih delavcev se zahteva, da poročajo o katerem koli domnevnemm neželenem učinku zdravila na nacionalni center za poročanje, ki je naveden v Prilogi V.
You may experience any of the side effects described in section 4.
Lahko se pojavijo kateri koli neželeni učinki, opisani v poglavju 4.
357 patients from the placebo-controlled study entered a long-term extension study.
357 bolnikov iz s placebom kontrolirane študije je bilo vključenih v dolgoročno podaljšano študijo.
If you experience sudden decrease or loss of vision, contact your doctor immediately.
Če doživite nenadno poslabšanje ali izgubo vida, se takoj obrnite na zdravnika.
Vomiting, Gastroesophageal reflux
bruhanje, gastroezofagealni refluks
If you have taken or are planning to take ADCIRCA, avoid excessive drinking (over 5 units of alcohol), since this may increase the risk of dizziness when standing up.
ADCIRCA, se izogibajte prekomernemu pitju (več kot 5 enot alkohola), saj lahko to vpliva na tveganje za omotico pri vstajanju.
Patients were randomised to one of five treatment groups (tadalafil 2.5 mg, 10 mg, 20 mg, 40 mg, or placebo).
Bolnike so randomizirali v eno od petih skupin zdravljenja: (2,5 mg, 10 mg, 20 mg, 40 mg tadalafila ali placebo).
INFORMATION IN BRAILLE ADCIRCA 20 mg
PODATKI V BRAILLOVI PISAVI ADCIRCA 20 mg
Haemodialysis contributes negligibly to tadalafil elimination.
Hemodializa zanemarljivo prispeva z izločanju tadalafila.
Single doses of up to 500 mg have been given to healthy subjects, and multiple daily doses up to 100 mg have been given to patients with erectile dysfunction.
Enkratne odmerke do 500 mg so dajali zdravim posameznikom, večkratne dnevne odmerke do 100 mg pa so dajali bolnikom z erektilno disfunkcijo.
Do NOT take a double dose to make up for the one that you have forgotten.
NE vzemite dvojnega odmerka, če ste pozabili vzeti prejšnji odmerek.
Tadalafil did not affect the exposure (AUC and Cmax) of bosentan or its metabolites.
Tadalafil ni vplival na biološko uporabnost (AUC in Cmax) bosentana in njegovih metabolitov.
Major classes of antihypertensive medicinal products were studied either as monotherapy or as part of combination therapy.
V študijo so bili vključeni poglavitni razredi antihipertenzivnih zdravil; kot monoterapija in kot del kombinirane terapije.
If you take more ADCIRCA than you should If you or anyone else takes more tablets than they should, tell your doctor or go to a hospital immediately, taking the medicine or pack with you.
Če ste vzeli večji odmerek zdravila ADCIRCA, kot bi smeli Če vi ali kdor koli drug zaužije več tablet, kot bi morali, to takoj povejte zdravniku ali pojdite v bolnišnico.
These effects are unlikely to lead to a lack of fertility.
Malo verjetno je, da bi ti učinki povzročili zmanjšanje plodnosti.
Patients were at least 12 years of age and had a diagnosis of PAH that was idiopathic, related to collagen disease, related to anorexigen use, related to human immunodeficiency virus (HIV) infection, associated with an atrial-septal defect, or associated with surgical repair of at least 1 year in duration of a congenital systemic-to-pulmonary shunt (for example, ventricular septal defect, patent ductus arteriosus).
Bolniki so bili stari vsaj 12 let in so imeli diagnozo PAH, ki je bila idiopatska, povezana z vaskularno sistemsko boleznijo vezivnega tkiva, povezana z uporabo anoreksigena, povezana z okužbo s človeškim virusom imunske pomanjkljivost (HIV), povezana z z atrijskim septalnim defektom ali pa v povezavi s kirurško popravo kongenitalnega sistemsko-pljučnega šanta, ki je bila opravljena pred ne manj kot enim letom (npr. ventrikularni septalni defekt, patent ductus arteriosus).
Changes in the Borg dyspnoea score were small and non-significant with both placebo and tadalafil 40 mg.
Spremembe v rezultatu dispneje po Borgu so bile majhne in nepomembne, tako pri placebu kot pri 40 mg tadalafila.
Available pharmacodynamic/toxicological data in animals have shown excretion of tadalafil in milk.
Farmakodinamski/toksikološki podatki pri živalih, ki so na voljo, so pokazali, da se tadalafil izloča v mleko.
If you have a mild or moderate liver or kidney problem, your doctor may advise you to take only one 20 mg tablet per day.
Če imate blage ali zmerne težave z jetri ali ledvicami, vam bo zdravnik morda svetoval, da vzamete le eno 20 mg tableto na dan. Pogoltnite celi tableti z nekaj vode.
The safety and efficacy of ADCIRCA in the paediatric population has not yet been established.
Pediatrična populacija Varnost in učinkovitost zdravila ADCIRCA pri pediatrični populaciji še nista bili dokazani.
In addition, no changes in tadalafil concentrations were seen after co-administration with alcohol.
Prav tako niso opazili sprememb koncentracij tadalafila ob sočasnem jemanju z alkoholom.
ADCIRCA 20 mg is available in blister packs containing 28 or 56 tablets.
Zdravilo ADCIRCA 20 mg je na voljo v pretisnih omotih z 28 ali 56 tabletami.
Orange and almond shaped film-coated tablets, marked "4467" on one side.
Filmsko obložene tablete oranžne barve in mandljeve oblike, z oznako “4467” na eni strani.
Pharmacotherapeutic group: Urologicals, drugs used in erectile dysfunction, ATC code: G04BE08.
Farmakoterapevtska skupina: Zdravila za bolezni sečil, Zdravila za zdravljenje erektilne disfunkcije, Oznaka ATC: G04BE08.
In patients receiving concomitant antihypertensive medicinal products, tadalafil 20 mg may induce a blood pressure decrease, which (with the exception of doxazosin -see above) is, in general, minor and not likely to be clinically relevant.
Pri bolnikih, ki sočasno prejemajo antihipertenzivna zdravila, lahko tadalafil 20 mg povzroči znižanje krvnega tlaka, ki je (z izjemo doksazocina - glejte zgoraj) v splošnem majhno in ni verjetno, da bi bilo klinično pomembno.
Unstable angina pectoris, Ventricular arrhythmia, Myocardial Infarction2
nestabilna angina pektoris, ventrikularna aritmija, miokardni infarkt2
Effects were seen in dogs that might indicate impairment of fertility.
Pri psih so bili opaženi učinki, ki morda kažejo na zmanjšanje plodnosti.
The rate and extent of absorption of tadalafil are not influenced by food, thus ADCIRCA may be taken with or without food.
Ker hrana ne vpliva na stopnjo in obseg absorpcije tadalafila, se lahko zdravilo ADCIRCA vzame s hrano ali brez nje.
Cardiopulmonary hemodynamics was performed in 93 patients.
Srčno-pljučni pretok krvi je bil izmerjen pri 93 bolnikih.
Results were generally consistent in subgroups according to age, gender, PAH aetiology and baseline WHO functional class and 6MWD.
V večini primerov so bili rezultati med različnimi podskupinami glede na starost, spol, etiologijo PAH in začetni funkcijski razred po razvrstitvi SZO ter 6MWD skladni.
The only pharmacodynamic effect was a small (3.5 bpm) increase in heart rate.
Edini farmakodinamični učinek je bil manjše zvišanje srčne frekvence (za 3,5 utripa na minuto).
Doses studied were 20 mg and 40 mg once daily.
Proučevali so odmerke 20 mg in 40 mg enkrat na dan.
Three studies were conducted in men to assess the potential effect on spermatogenesis of tadalafil 10 mg (one 6-month study) and 20 mg (one 6-month and one 9-month study) administered daily.
Pri moških so izvedli tri študije za ugotavljanje možnega učinka tadalafila v odmerku 10 mg (ena 6mesečna študija) in 20 mg (ena 6-mesečna in ena 9-mesečna študija), ki so ga dajali na dan, na spermatogenezo.
Some side effects have been rarely reported: - Partial, temporary or permanent decrease or loss of vision in one or both eyes and serious allergic reaction which causes swelling of the face or throat.
- delna, začasna ali stalna izguba vida na eno ali obe očesi in resno alergijsko reakcijo, ki povzroči otekanje obraza ali grla.
Tadalafil exposure (AUC) in patients with diabetes was approximately 19 % lower than the AUC value for healthy subjects after a 10 mg dose.
Izpostavljenost tadalafilu (AUC) je bila pri bolnikih s sladkorno boleznijo približno 19 % nižja kot vrednost AUC za zdrave osebe po dajanju odmerka 10 mg.
ADCIRCA contains lactose If you know you have an intolerance to some sugars, contact your doctor before taking this medicine.
Zdravilo ADCIRCA vsebuje laktozo Če veste, da ne prenašate nekaterih sladkorjev, se pred jemanjem tega zdravila obrnite na zdravnika.
Although the frequency of reports of dizziness in placebo and tadalafil arms in clinical studies was similar, patients should be aware of how they react to ADCIRCA, before driving or operating machinery.
da so bile pogostnosti poročanja o omotici v skupinah prejemanja placeba in tadalafila v kliničnih študijah podobne, naj se bolniki pred vožnjo ali upravljanjem strojev zavedajo, kako se odzovejo na zdravilo ADCIRCA.
Tadalafil is readily absorbed after oral administration and the mean maximum observed plasma concentration (Cmax) is achieved at a median time of 4 hours after dosing.
Tadalafil se po peroralnem dajanju hitro absorbira, povprečna maksimalna opažena plazemska koncentracija (Cmax) je dosežena ob medianem času 4 ure po odmerjanju.
Pharmacokinetic studies have included subjects and patients from different ethnic groups, and no differences in the typical exposure to tadalafil have been identified.
Farmakokinetične študije so vključevale osebe in bolnike različnih etničnih skupin; opazili niso nobenih razlik v izpostavljenosti tadalafilu.
A single study has been performed in paediatric patients with Duchenne Muscular Dystrophy (DMD) in which no evidence of efficacy was seen.
S pediatričnimi bolniki z Duchennovo mišično distrofijo (DMD) so opravili eno samo študijo, v kateri niso opazili nobenih dokazov o učinkovitosti.
Tadalafil should be used with caution in patients with anatomical deformation of the penis (such as angulation, cavernosal fibrosis or Peyronie's disease), or in patients who have conditions which may predispose them to priapism (such as sickle cell anaemia, multiple myeloma or leukaemia).
Tadalafil je potrebno previdno uporabljati pri bolnikih z anatomsko deformacijo penisa (kot so ukrivljenost, kavernozna fibroza ali Peyroniejeva bolezen), ali pri bolnikih s stanji, ki bi lahko povečala dovzetnost za priapizem (kot so srpastocelična anemija, multipli mielom ali levkemija).
Tadalafil is
Tadalafil je
Between 20 mg to 40 mg, a less than proportional increase in exposure is observed.
Pri odmerkih od 20 mg do 40 mg so opazili manj sorazmerno rast.
In the pregnant rat the AUC for calculated free active substance at this dose was approximately 18 times the human AUC at a 20 mg dose.
Pri breji podgani je bila AUC za izračunano prosto učinkovino pri tem odmerku približno 18-kratna AUC človeka pri 20 mg odmerku.
In patients with pulmonary hypertension not receiving concomitant bosentan, the average tadalafil exposure at steady-state following 40 mg was 26 % higher when compared to those of healthy volunteers.
Pri bolnikih s pljučno hipertenzijo, ki se sočasno niso zdravili z bosentanom, je bila povprečna izpostavljenost tadalafilu v stanju dinamičnega ravnovesja po prejetju odmerka 40 mg za 26 % višja v primerjavi z zdravimi prostovoljci.
Although it is not known if the event is directly related to tadalafil, if you experience decreased or sudden hearing loss, contact your doctor immediately.
Čeprav ni znano, ali je ta dogodek neposredno povezan s tadalafilom, se morate v primeru poslabšanja ali nenadne izgube sluha takoj obrniti na zdravnika.
Posology The recommended dose is 40 mg (2 x 20 mg) taken once daily with or without food.
Odmerjanje Priporočeni odmerek je 40 mg (2 x 20 mg) enkrat na dan, zaužit s hrano ali brez nje.
The safety and efficacy of combinations of tadalafil and other endothelin-1 receptor antagonists have not been studied.
Varnost in učinkovitost kombinacij tadalafila z drugimi antagonisti receptorja za endotelin-1 nista bili preučevani.
In patients taking multiple antihypertensive medicinal products whose hypertension was not well controlled, greater reductions in blood pressure were observed compared to patients whose blood pressure was well controlled, where the reduction was minimal and similar to that in healthy subjects.
Pri bolnikih, ki so jemali več različnih antihipertenzivnih zdravil in pri katerih krvni tlak ni bil dobro nadzorovan, so opazili večje znižanje krvnega tlaka v primerjavi z bolniki, pri katerih je bil krvni tlak dobro nadzorovan.
OTHER Mon, Tue, Wed, Thu, Fri, Sat, Sun.
PON, TOR, SRE, ČET, PET, SOB, NED
It belongs to a group of medicines called phosphodiesterase type 5 (PDE5) inhibitors which work by helping the blood vessels around your lungs relax, improving the flow of blood into your lungs.
Spada v skupino zdravil, imenovanih zaviralci fosfodiesteraze tipa 5 (zaviralci PDE5), ki delujejo tako, da pomagajo pri sproščanju (širjenju) krvnih žil okoli pljuč, kar izboljša pretok krvi v pljuča.
These events have either been assigned a frequency of “Not known,” as the frequency in PAH patients cannot be estimated from the available data or assigned a frequency based on the clinical study data from the pivotal placebo-controlled study of ADCIRCA.
Pogostnost teh učinkov je označena ali kot pogostnost »neznana«, saj se pogostnosti pri bolnikih s PAH ne more oceniti na osnovi podatkov, ki so na voljo, ali kot pogostnost na osnovi podatkov kliničnih študij iz ključne, s placebom kontrolirane študije zdravila ADCIRCA.
Sudden cardiac death2, 5, Tachycardia2, 5
nenadna srčna smrt2,5, tahikardija2,5
Long-term treatment
Dolgotrajno zdravljenje
Allowed background therapy included bosentan (stable maintenance dose up to 125 mg twice daily) and chronic anticoagulation, digoxin, diuretics and oxygen.
Dovoljena osnovna terapija je vključevala bosentan (stabilen vzdrževalni odmerek do 125 mg dvakrat na dan), kronično antikoagulantno zdravljenje, digoksin,
PDE5 is the predominant phosphodiesterase in the pulmonary vasculature.
PDE5 je poglavitna fosfodiesteraza v pljučnem žilju.
Pulmonary vasodilators may significantly worsen the cardiovascular status of patients with pulmonary veno-occlusive disease (PVOD).
Pljučni vazodilatatorji lahko znatno poslabšajo srčno-žilno stanje bolnika z veno-okluzivno boleznijo pljuč (PVOD - pulmonary veno-occlusive disease).
When dogs were treated there was reduced sperm development in the testes.
Ko so zdravilo dajali psom, so opazili zmanjšano nastajanje sperme v modih.
> 10,000-fold more potent for PDE5 than for PDE3, an enzyme found in the heart and blood vessels.
> 10.000-krat močnejši za PDE5 kot za PDE3, encim, ki se nahaja v srcu in krvnih žilah.
However, post hoc analyses demonstrated that changes from baseline in cardiopulmonary hemodynamic parameters for the tadalafil 40 mg treatment group were not significantly different compared to placebo.
Vendar so post-hoc analize pokazale, da se vrednosti parametrov srčno-pljučnega pretoka glede na osnovno vrednost pri skupini, ki se je zdravila s 40 mg tadalafila, v primerjavi s placebom niso pomembno razlikovale.
Other side effects have been reported:
Poročali so o tudi o drugih neželenih učinkih:
Improvements compared to placebo were observed with tadalafil 40 mg in the EuroQol (EQ-5D) US and UK index scores comprising mobility, self-care, usual activities, pain/discomfort, anxiety/depression components, and in the visual analogue scale (VAS).
Izboljšanje pri uporabi 40 mg tadalafila v primerjavi s placebom so opazili na lestvici EuroQol (EQ5D), ki je ameriška in britanska lestvica za oceno mobilnosti, samooskrbe, rutinskih dejavnosti, bolečine/nelagodja in anksioznosti/depresije na vizualni analogni lestvici.
Additionally, 6 minute walk distance and WHO functional class status appeared to be stable in those treated with tadalafil for 1 year.
Poleg tega sta bila 6MWD in funkcijski razred po razvrstitvi SZO pri bolnikih, ki so se zdravili 1 leto, stabilna.
ADCIRCA contains lactose monohydrate.
Zdravilo ADCIRCA vsebuje laktozo monohidrat.
The usual dose is two 20 mg tablets taken once a day.
Običajni odmerek sta dve 20 mg tableti enkrat na dan.
In healthy female and male subjects following single and multiple-doses of tadalafil, no clinically relevant differences in exposure were observed.
Pri zdravih moških in ženskah po dajanju enkratnega in večkratnega odmerku tadalafila klinično pomembnih sprememb v izpostavljenosti niso opazili.
Sudden decrease or loss of hearing has also been reported.
Poročali so tudi o nenadnem poslabšanju ali izgubi sluha.
Due to increased tadalafil exposure (AUC), limited clinical experience, and the lack of ability to influence clearance by dialysis, tadalafil is not recommended in patients with severe renal impairment.
Zaradi povečane biološke uporabnosti (AUC) tadalafila, malo kliničnih izkušenj in nezmožnosti vplivanja na očistek z dializo, se uporaba tadalafila pri bolnikih s hudo okvaro ledvic ne priporoča.
Tadalafil has systemic vasodilatory properties that may result in transient decreases in blood pressure.
Tadalafil ima sistemsko vazodilatorno delovanje, kar lahko povzroči prehodna znižanja krvnega tlaka.
Use with CYP3A4 inducers or inhibitors
Uporaba z induktorji in zaviralci CYP3A4
The incidence of clinical worsening by week 16 in patients treated with tadalafil 40 mg (5 %; 4 of 79 patients) was less than placebo (16 %; 13 of 82 patients).
Pogostnost kliničnega poslabšanje do 16. tedna je bila nižja pri bolnikih, ki so dobivali 40 mg tadalafila (5 %; 4 od 79 bolnikov) kot pri bolnikih, ki so prejemali placebo (16 %; 13 od 82 bolnikov).
The safety and efficacy of combinations of tadalafil and other PDE5 inhibitors or other treatments for erectile dysfunction have not been studied.
Varnosti in učinkovitosti kombinacij tadalafila z drugimi zaviralci PDE5 ali drugimi zdravili za erektilno disfunkcijo niso preučevali.